Device Medical Device

(9520) Igt Devices Und

Payments companies reported to CMS as associated with (9520) Igt Devices Und. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$151Kassociated payments (2023-2025)
121clinicians with associated payments
2companies reporting

By year

2023 $61K
2024 $90K

Payments reported as associated with (9520) Igt Devices Und, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Cardiovascular Disease $63K
Clinical Cardiac Electrophysiology $42K
Interventional Cardiology $35K
Thoracic Surgery (Cardiothoracic Vascular Surgery) $4,783
Vascular Surgery $3,628
Medical $1,116

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with (9520) Igt Devices Und

These are the largest totals companies reported as associated with (9520) Igt Devices Und. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Edris Aman Sacramento, CA Cardiovascular Disease $23,638.02
Gagan Singh Sacramento, CA Cardiovascular Disease $15,680.00
Markus Scherer Charlotte, NC Cardiovascular Disease $11,755.20
Andrew Goldsweig Omaha, NE Interventional Cardiology $10,200.00
Prashanth Thakker Saint Louis, MO Interventional Cardiology $9,400.00
Shephal Doshi Santa Monica, CA Clinical Cardiac Electrophysiology $7,500.00
Ricardo Lugo Nashville, TN Clinical Cardiac Electrophysiology $6,580.00
Auroa Badin Columbus, OH Clinical Cardiac Electrophysiology $6,250.00
Karim Al-Azizi Plano, TX Interventional Cardiology $4,375.00
Brandon Roy-Garland Denver, CO Vascular Surgery $3,600.00

Prescribed (9520) Igt Devices Und?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.